Fate Therapeutics (FATE) Files 5.25M Share Common Stock Shelf for SHareholders

September 12, 2016 4:12 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Fate Therapeutics (NASDAQ: FATE) filed a registration with the U.S. SEC to sell up to 5,250,000 shares of common stock on behalf of selling shareholders.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Related Entities


Add Your Comment